Boyne Wade Brewer

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 1 buy · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€30k

▼ Sales (0 ops.)

—

Latest filing published 23 Sept 2026 for ENNIS, INC., €34k. Read the official filing

Filing timeline

BuySale

Boyne Wade Brewer

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+16.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Boyne Wade Brewer: trading record in brief

Boyne Wade Brewer appears in our data through filings on Ennis, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 16 September 2022 to 22 September 2026, the count stands at 9 filings.

On the market, this insider has only ever bought: 1 purchase, €30k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 3 option exercises.

The latest filing, published on 23 September 2026, reports a transaction of €34k in Ennis, Inc. The clock since the last published purchase (3 November 2025) now reads 349 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.